Gladstone Institutional Advisory’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,614	Closed	-$398K	–	280
2020 Q2	$398K	Buy	11,614 +1,727	+17%	+$59.2K	0.1%	149
2020 Q1	$220K	Buy	+9,887	New	+$220K	0.06%	237